Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ODOMZO

SONIDEGIB PHOSPHATE

Standard Dose
EQ 200MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ODOMZO is listed in Drugs@FDA under application 205266 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SONIDEGIB PHOSPHATE Form and strength CAPSULE;ORAL - EQ 200MG BASE Sponsor SUN PHARM Submission history Latest submission status date: 2023-08-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview ODOMZO is listed in Drugs@FDA under application 205266 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SONIDEGIB PHOSPHATE Form and strength CAPSULE;ORAL - EQ 200MG BASE Sponsor SUN PHARM Submission history Latest submission status date: 2023-08-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.